Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
about
Sirt3 attenuates doxorubicin-induced cardiac hypertrophy and mitochondrial dysfunction via suppression of Bnip3.Role of microRNAs in doxorubicin-induced cardiotoxicity: an overview of preclinical models and cancer patients.Identification of prognostic signature in cancer based on DNA methylation interaction network.MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment.
P2860
Circulating miR-1 as a potential biomarker of doxorubicin-induced cardiotoxicity in breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@en
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@nl
type
label
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@en
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@nl
prefLabel
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@en
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Circulating miR-1 as a potenti ...... ity in breast cancer patients.
@en
P2093
Cecilia B B V Cruz
Edimar A Bocchi
Fátima D Cruz
Guilherme V Guimarães
Ludmila R P Ferreira
Marco S L Alves
Marília H H Santos
Mônica S Ávila
Sara M G Brandão
Silvia M Ayub-Ferreira
P2860
P304
P356
10.18632/ONCOTARGET.14355
P407
P577
2016-12-29T00:00:00Z